About Eric Ostertag

Dr. Ostertag is an American scientist and inventor of several patented gene engineering technologies. He was the first graduate from the Gene Therapy Program at the University of Pennsylvania School of Medicine and has over 20 years of experience in cell and gene engineering, founding multiple biotechnology companies, including Poseida Therapeutics and Transposagen Biopharmaceuticals. Dr. Ostertag served as Transposagen’s Chief Executive Officer and President for 13 years. Transposagen is a biotechnology company that commercializes early gene editing technology in the research reagent space. There, Dr. Ostertag led the development of next-generation gene engineering technologies that were eventually spun out to create Poseida Therapeutics, in early 2015, where he currently serves as CEO.